Oncology

Latest News

AJMC Q&A with Eileen Peng, PharmD | Background image credit: ipopba - stock.adobe.com

The Role of Pharmacists Expands Beyond Dispensing for Novel Cancer Therapies: Eileen Peng, PharmD

By Laura Joszt, MA
Eileen Peng, PharmD

May 21st 2025

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is transforming the role of pharmacists in enhancing patient care.

Future validation studies with a larger sample size are warranted to ensure the technique will be useful in a clinical setting. | Image credit: Artur Wnorowski - stock.adobe.com

Novel, Noninvasive Skin Cancer Detection Method Shows Promise

By Jared Kaltwasser

May 18th 2025

FDA Approved | Image credit: chrisdorney – stock.adobe.com

Teliso-V Approved to Treat Advanced NSCLC With High c-Met Protein Overexpression

By Hayden E. Klein

May 14th 2025

While CTCs were identified regardless of disease stage, the current study identified large variations in the presence of CTCs between nonmetastatic and metastatic disease | Image Credit: Innovative Creation - stock.adobe.com

Flow Cytometry Can Reliably Identify CTC in Melanoma

By AJMC Contributor

May 14th 2025

Jack & Sheryl Morris Cancer Center | Image credit: RWJBarnabas Health

New Jersey’s First Freestanding Cancer Hospital Opens in New Brunswick

By Pearl Steinzor

May 14th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

February 16th 2015

FDA Approves Palbociclib for Metastatic Breast Cancer

February 16th 2015

Reality Meets ASCO's Policy Statement on Medicaid Reform

February 16th 2015

Lung Cancer Breath Test Might Soon Be Reality

Researchers at the University of Leicester and Leicester's Hospitals are evaluating a revolutionary device which detects lung cancer in early stages.

February 16th 2015

Patient Cost-Sharing in Oncology and the Patient Access Network Foundation

February 15th 2015

Commission on Cancer and the Oncology Medical Home

Daniel P. McKellar, MD, FACS

February 15th 2015

Immuno-Oncology Poised to Revolutionize Patient Care

Lee S. Schwartzberg, MD, FACP

February 15th 2015

The Promise of Immuno-Oncology

Surabhi Dangi-Garimella, PhD

February 15th 2015

Money Well Spent: the Need for Federal Funding in Cancer Research

John R. Seffrin, PhD

February 14th 2015

Managed Care Minute: February 14, 2015

A one-minute look at managed care news during the week of February 9, 2015, including an announcement of a new Affordable Care Initiative and a potential change to recommended dietary guidelines.

February 13th 2015

Cancer Patients Rarely Request Inappropriate Tests, Treatments

Laura Joszt, MA

A new study debunks the common assumption that high medical costs are a result of patients demanding more tests and treatments. Researchers analyzed more than 5000 patient-clinician visits and found that cancer patients rarely push for medical interventions.

February 12th 2015

Order of Cancer Gene Mutations Could Influence Treatment Choice

The NEJM study, although specific for blood disorders, could be extrapolated to other tumor types as well, to develop personalized treatment regimens, the authors suggest.

February 12th 2015

HHS Announces New Oncology Care Management Initiative

Laura Joszt, MA

A new Affordable Care Act initiative from HHS will better coordinate cancer care with the intention of improving the quality of care provided and reducing the money spent on healthcare, according to an announcement from HHS.

Dr Debra Patt Discusses Community Oncology Practices

February 12th 2015

Dr Debra Patt Discusses Community Oncology Practices

As community oncology clinics affiliate with hospital systems to become hospital outpatient departments, patients begin to feel the burden of higher costs of care, according to Debra Patt, MD, from Texas Oncology, a community-based practice.

Segment 11: High Cost Trends Trickling Into Other Disease Areas

February 12th 2015

Segment 11: High Cost Trends Trickling Into Other Disease Areas

Although the marketplace has managed to come to a temporary solution for the high cost of hepatitis C drugs, Steven Miller, MD, MBA, expects to see more examples of similar high-cost drugs in other categories.

February 12th 2015

New Approach Reduces Length of Stay, Costs in Colorectal Surgery

Laura Joszt, MA

A new approach to caring for patients undergoing colorectal surgery has shown faster recovery times, fewer complications, improved patient satisfaction, and reduced medical costs, according to a team of researchers.

February 11th 2015

Confirmed: Valeant to Buy Dendreon

Following reports last week of a bid, it has now been confirmed that the Canadian company Valeant Pharmaceuticals International Inc will buy Provenge-maker Dendreon.

February 11th 2015

Rare EGFR Mutations Need Additional Scrutiny in NSCLC, Study Warns

The results published in the Journal of Thoracic Oncology found that the response rate to tyrosine kinase inhibitor therapy was significantly higher in classic vs rare EGFR mutations.

Dr Bruce Feinberg Highlights Pathways as a Solution to High Costs in Oncology

February 10th 2015

Dr Bruce Feinberg Highlights Pathways as a Solution to High Costs in Oncology

The concept of pathways is the most widely adopted solution to reduce the high cost of cancer care, according to Bruce Feinberg, DO, vice president and chief medical officer of oncology at Cardinal Health Specialty Solutions.

February 10th 2015

Service Setting Impact on Costs for Bevacizumab-Treated Oncology Patients

Nicole M. Engel-Nitz, PhD Elaine B. Yu, PharmD, MS Laura K. Becker, MS Art Small, MD

For patients with lung or colorectal cancer, bevacizumab treatment patterns and healthcare costs varied by the setting of treatment initiation (physician office vs hospital outpatient).

February 10th 2015

Genetic Variation Could Prompt Hearing Loss in Young Cancer Patients on Cisplatin

St. Jude Children's Research Hospital investigators have discovered inherited genetic variations associated with rapid hearing loss in young cancer patients treated with the drug cisplatin, as published in Nature Genetics.

February 10th 2015

Takeda's Ixazomib Improves PFS in Multiple Myeloma, Interim Analysis Finds

Interim analysis during a phase 3 study of Ixazomib in patients with relapsed or refractory multiple myeloma found that the drug improved the primary endpoint of progression-free survival.

February 9th 2015

Velcade Approved for Mantle Cell Lymphoma in Europe

The drug has been approved for treatment-naive patients who are ineligible for transplant.

February 6th 2015

FDA Approval for 3D Breast Imaging System Developed by an Academic Startup

The 3D breast imaging system, developed at the University of Rochester, is currently approved for diagnosing cancer in women who have signs or symptoms of the disease, or who have abnormal findings after a standard screening mammogram.

February 6th 2015

CMS Adds Medicare Coverage for LDCT Screening for Lung Cancer in Certain Patients

Mary K. Caffrey

Following an announcement that Medicare would cover preventive low dose computes tomography for lung cancer screening, CMS released a final national coverage determination today that includes details on eligibility criteria.

February 5th 2015

Study Results Support Early Treatment With Abiraterone in Prostate Cancer

Surabhi Dangi-Garimella, PhD

A study published in the journal Lancet Oncology, conducted by the Institute of Cancer Research (ICR), London, provides evidence for the value of introducing abiraterone prior to chemotherapy in these patients.

February 5th 2015

Strategic Oncology Partnership Between AstraZeneca and MD Anderson

The industry-academic partnership is expected to boost clinical trials on investigational drugs and outcomes research, in gynecological cancers.

February 5th 2015

Pfizer to Buy Injectables Giant Hospira

With several of it's blockbusters going off-patent soon, Pfizer is looking at new avenues for expanding it's revenue.

February 5th 2015

FDA Commissioner Hamburg Stepping Down

After nearly 6 years overseeing public health initiatives, Margaret Hamburg, MD, commissioner of the FDA will be stepping down, according to various sources.

February 4th 2015

Smoking Increases Risk of Mortality in CRC Survivors

A comprehensive study published in the Journal of Clinical Oncology found that colorectal cancer survivors who smoke cigarettes were at more than twice the risk of death than non-smoking survivors.

February 4th 2015

Evidence-Based Care Can Eliminate Gaps in Cancer Survival Rates

Laura Joszt, MA

Although African Americans have had lower colon cancer survival rates over the past 2 decades compared with white patients, researchers at the Stanford University School of Medicine have found evidence-based care can remove the racial disparity.

...

138 139 140 141 142 143 144 145 146

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions